Spain self
diagnostics market is anticipated to witness a growth of steady CAGR in the
forecast period, 2024-2028. The self diagnostics market in Spain has witnessed
significant growth over the past few years, owing to the rise in elderly population in the country. Spain is facing a demographic
shift with an aging population that is projected to have a significant impact
on the country’s economy, healthcare system, and society. The demographic
transition, marked by an increase in life expectancy and a decrease in
fertility rates, has caused a significant change in the population structure in
Spain. According to the National Institute of Statistics, over 20% of
Spain's population is currently aged 65 years or older, and this is projected
to increase to 30% by 2050. This trend is attributed to several factors,
including increased life expectancy, improved healthcare, and a decrease in
birth rates. One of the significant challenges posed by an aging population is
the increased demand for healthcare services. The elderly is more prone to chronic
conditions such as cardiovascular disease, diabetes (according to the World
Bank, diabetes prevalence was reported at 10.3% in 2021), cancer, and
dementia, which require long-term care and management. According to the
European Society of Cardiology (ESC), cardiovascular disease accounts for about
32% of all Spanish deaths. The increased demand for healthcare services may
put a strain on the existing healthcare infrastructure and resources, leading
to longer wait times and reduced access to care. This may in turn augment the
market growth of Spain self diagnostics market.
On the other
hand, the aging population also presents opportunities for innovation and
economic growth. For instance, the demand for healthcare services presents an
opportunity for the development of innovative products and services that cater
to the needs of the elderly. There is also an opportunity for the development
of technology-driven solutions such as remote healthcare monitoring systems,
wearable health devices, telemedicine, and self diagnostic kits.
Also, chronic
diseases have become a significant public health concern in Spain, with a
steady increase in their prevalence over the years. Chronic diseases are
long-term conditions that require ongoing management and can significantly
impact the quality of life of affected individuals. A contributing factor to
chronic diseases is unhealthy lifestyle, such as poor diet, lack of exercise,
and smoking. These lifestyle factors increase the risk of developing chronic
diseases such as obesity, type 2 diabetes, and cardiovascular disease. In
Spain, the consumption of unhealthy food and beverages has increased over the
years, leading to a rise in obesity and related conditions.
Another
principal advantage of self-testing kits is that they can reduce healthcare
costs by reducing the need for medical appointments and laboratory tests. For
example, individuals who suspect they have a sexually transmitted infection
(STI) can use a self-testing kit to diagnose the condition at home, rather than
visiting a clinic or doctor's office. This can save both time and money, as
well as reducing the burden on healthcare services. Self-testing kits can also
lead to earlier diagnosis and treatment, which can improve health outcomes and
reduce the cost of long-term care. For example, individuals who use
self-testing kits for conditions such as HIV, hepatitis C, or diabetes can
detect these conditions earlier, allowing for prompt treatment and management.
This can reduce the risk of complications and hospitalization, and ultimately
save money in the long run.
A Rise in Point-of-Care (POC) Diagnostics in Spain
Point-of-care diagnostics (POC) refers to medical tests that can be
performed at or near the site of patient care, providing immediate results. In
Spain, there has been an increasing trend towards the use of POC diagnostics in
recent years.
One of the primary reasons for the increasing use of POC diagnostics in
Spain is the need for timely and accurate diagnosis. POC diagnostics provide
rapid results, which can be crucial in situations where time is of the essence,
such as in emergency departments and critical care units. This can lead to
faster diagnosis and treatment, resulting in improved patient outcomes.
Another factor is the growing demand for decentralized healthcare
services. POC diagnostics can be used in a wide range of settings, including
community clinics, primary care centers, and even patient homes. This allows
for greater accessibility to healthcare services, particularly for individuals
who may have limited access to traditional healthcare facilities.
Furthermore, POC diagnostics can help reduce the burden on the
healthcare system by reducing the need for expensive laboratory tests and
referrals. This can lead to cost savings and increased efficiency in healthcare
delivery.
The benefits of increasing the use of POC diagnostics in Spain are
significant. Firstly, it can lead to improved patient outcomes by providing
timely and accurate diagnosis. Secondly, it can increase accessibility to
healthcare services, particularly for underserved populations. Lastly, it can
help reduce healthcare costs and increase efficiency in healthcare delivery.
Growing
Adoption of Self-diagnostic Kits in Spain
The
adoption of self-diagnostic kits in Spain has been on the rise in recent years.
Self-testing kits refer to medical tests that can be performed by patients
themselves, usually at home, without the need for a healthcare professional.
One
of the primary reasons for the growing adoption of self-testing kits in Spain
is convenience. Self-testing kits provide patients with the ability to perform
medical tests in the comfort of their own homes, without the need for a
healthcare professional or a visit to a medical facility. This can be
particularly beneficial for individuals with mobility or transportation issues
or those who live in remote areas.
Another
factor is the growing awareness of personal health monitoring. Self-testing
kits allow individuals to monitor their health status regularly, leading to
early detection of health problems and timely intervention. This can lead to
improved health outcomes and reduce the burden on the healthcare system by
reducing the need for expensive hospital visits and treatments.
Furthermore,
self-testing kits can help reduce the stigma associated with certain medical
conditions. For example, individuals who may feel embarrassed or uncomfortable
discussing sensitive health issues with a healthcare professional may feel more
comfortable performing self-tests in the privacy of their own homes.
The
benefits of self-testing kits in Spain are considerable. Firstly, they can lead
to improved health outcomes by providing early detection of health problems.
Secondly, they can increase accessibility to healthcare services, particularly
for individuals with limited mobility or living in remote areas. Lastly, they
can help reduce healthcare costs and increase efficiency in healthcare
delivery.
Ease
of Availability of Self-diagnostic Kits at Pharmacies in Spain
The
easy availability of self-diagnostic kits at pharmacies in Spain is a
relatively recent development that has brought about several changes in the
healthcare industry. Self-diagnostic kits are medical devices that allow
patients to test themselves for a variety of conditions, from pregnancy to
cholesterol levels, and many pharmacies in Spain now offer them over the
counter.
One
of the primary reasons for the easy availability of self-testing kits at
pharmacies in Spain, is the growing demand for patient empowerment. Patients
are increasingly taking an active role in managing their health, and
self-testing kits offer a way of an easy routine check-up. By making self-testing
kits readily available, pharmacies can provide patients more control over their
health, which can lead to improved health outcomes.
Another
factor driving the availability of self-testing kits at pharmacies is the ease
of use. Self-testing kits are simple to use, and patients can perform the tests
themselves at home, without the need for a healthcare professional. By making
self-testing kits available at pharmacies, patients can have easy access to
them and avoid having to make an appointment with a healthcare provider.
Furthermore,
the availability of self-testing kits at pharmacies can help reduce the burden
on the healthcare system. By enabling patients to monitor their health at home,
self-testing kits can reduce the number of unnecessary visits to healthcare
facilities, which can lead to cost savings and increased efficiency in
healthcare delivery.
Download Free Sample Report
Market
Segmentation
Spain self diagnostics market can be segmented
by test type, sample, usage, distribution channel, and region. Based on test type,
the market can be segmented into blood glucose testing, pregnancy &
fertility testing, cholesterol testing, urine testing, COVID-19 testing, and
others. Based on sample, the market can be divided into blood, urine, and
saliva. Based on usage, the market can be split into disposable and reusable.
Based on distribution channel, the market can be fragmented into retail
stores/retail pharmacies, hospital pharmacies, hypermarket/supermarket, and
e-commerce channels/online pharmacies.
Market Players
CerTest Biotec S.L., Technolarity
Diagnostics, Xiamen Boson Biotech Co., Ltd., Abbot España Laboratorios, Becton
Dickinson, S.A., Roche Diabetes Care Spain, S.L., and B. Braun Medical, S.A. are
some of the leading players operating in the Spain self diagnostics market.
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic
Data
|
2018 – 2021
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
|
Segments
Covered
|
Test Type
Sample
Usage
Distribution
Channel
Region
|
|
Regional
Scope
|
Central
Region North Spain; Aragon & Catalonia; Andalusia, Murcia & Valencia;
Madrid, and Extremadura & Castilla
|
|
Key
Companies Profiled
|
CerTest Biotec S.L., Technolarity Diagnostics, Xiamen
Boson Biotech Co., Ltd., Abbot España Laboratorios, Becton Dickinson, S.A.,
Roche Diabetes Care Spain, S.L., and B. Braun Medical, S.A.
|
|
Customization
Scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing
and Purchase Options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, Spain self
diagnostics market has been segmented into following categories, in addition to
the industry trends which have also been detailed below:
·
Spain
Self Diagnostics Market, By Test Type:
o
Blood Glucose
Testing
o
Pregnancy &
Fertility Testing
o
Cholesterol
Testing
o
Urine
Testing
o
COVID-19
Testing
o
Others
·
Spain
Self Diagnostics Market, By Sample:
o
Blood
o
Urine
o
Saliva
·
Spain
Self Diagnostics Market, By Usage:
o
Disposable
o
Reusable
·
Spain
Self Diagnostics Market, By Distribution Channel:
o
Retail Stores/Retail
Pharmacies
o
Hospital
Pharmacies
o
Hypermarket/Supermarket
o
E-Commerce
Channels/Online Pharmacies
·
Spain Self Diagnostics Market, By Region:
o Central Region North Spain
o Aragon & Catalonia
o Andalusia, Murcia & Valencia
o Madrid, Extremadura & Castilla
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Spain self diagnostics market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
Spain self diagnostics market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]